EXHIBIT 10.1
PAYMENT DEFERRAL AGREEMENT
This Payment Deferral Agreement ("Agreement") is entered into as of May 18, 2026, by and between:
**BioSpring Medical Co., Ltd. **("BioSpring"), and
**VitaSpring Biomedical Co., Ltd. **("VitaSpring").
1. Outstanding Balance
The parties acknowledge that, as of the date of this Agreement, VitaSpring owes BioSpring approximately USD 2,411,000 arising from prior purchases of products and related business transactions.
2. Payment Deferral
BioSpring agrees that it will not demand immediate repayment of the outstanding balance and agrees to defer collection efforts for a period of twenty-four (24) months from the effective date of this Agreement.
3. Repayment Understanding
The parties understand and agree that VitaSpring intends to begin repayment of the outstanding balance after its business and operating condition improves. The repayment schedule and timing may be mutually discussed and agreed upon by the parties at a later date.
4. lnterest
No interest shall accrue on the outstanding balance during the deferral period unless otherwise agreed by the parties in writing.
5. Nature of Obligation
This Agreement does not extinguish or forgive the outstanding balance, which shall remain payable by VitaSpring to BioSpring.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.
[Signature Page Follows]
| 1 |
| BioSpring Medical Co., Ltd. | ||
| Name: Title: | ![]() |
Date: May 18, 2026
| VitaSpring Biomedical Co., Ltd. | ||
| By: | /s/ Dr. Ssu-Chuan Lai | |
| Name: Dr. Ssu-Chuan Lai | ||
| Title: Chief Executive Officer | ||
| Date: May 18, 2026 |
| 2 |
